SCHEMBL7317038

SCHEMBL7317038

FC(c1ccccc1)(c1ccccc1)N1CCNCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 6/20 0.46
HTR3A P46098 5/20 0.46
HTR3E A5X5Y0 4/20 0.46
HTR3B O95264 4/20 0.46
HTR3D Q70Z44 4/20 0.46
HTR3C Q8WXA8 4/20 0.46
ALDH1A1 P00352 2/20 0.46
HTR1D P28221 2/20 0.46
HTR2C P28335 1/20 0.46
ADRB1 P08588 3/20 0.45
MAPT P10636 1/20 0.45
THRB P10828 1/20 0.45
CHRM2 P08172 1/20 0.42
CHRM4 P08173 1/20 0.42
CHRM5 P08912 1/20 0.42
CHRM1 P11229 1/20 0.42
CHRM3 P20309 1/20 0.42
SLC6A4 P31645 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28026925 0.85 SIGMAR1 (0.39) SIGMAR1HTR3AHTR3EHTR3BHTR3D
SCHEMBL9202300 0.80 CHRM2 (0.46) SIGMAR1HTR3AHTR3EHTR3BHTR3D
SCHEMBL569963 0.79 SIGMAR1 (0.48) SIGMAR1HTR3AHTR3EHTR3BHTR3D
SCHEMBL12469656 0.79 CYP2B6 (0.59) SIGMAR1ALDH1A1CHRM2CHRM4CHRM5
SCHEMBL16672397 0.78 SIGMAR1 (0.41) SIGMAR1HTR3AHTR3EHTR3BHTR3D
SCHEMBL8411629 0.78 SIGMAR1 (0.47) SIGMAR1HTR3AHTR3EHTR3BHTR3D
SCHEMBL9090858 0.78 SIGMAR1 (0.47) SIGMAR1HTR3AHTR3EHTR3BHTR3D
SCHEMBL16052072 0.77 SIGMAR1 (0.41) SIGMAR1HTR3AHTR3EHTR3BHTR3D
SCHEMBL9530943 0.76 SIGMAR1 (0.46) SIGMAR1HTR3AHTR3EHTR3BHTR3D
SCHEMBL11114653 0.76 SIGMAR1 (0.45) SIGMAR1HTR3AHTR3EHTR3BHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0159566-A1 Novel piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient KANEBO, LTD. (JP) 1985-10-30 EP claimed
US-4663325-A 1-(2,3,4-tri-methoxybenzyl)-4[bis(4-fluorophenyl)methyl] piperazines are useful for treating cerebrovascular disease KANEBO LTD. (JP) 1987-05-05 US disclosed
US-4663325-A 1-(2,3,4-tri-methoxybenzyl)-4[bis(4-fluorophenyl)methyl] piperazines are useful for treating cerebrovascular disease KANEBO LTD. (JP) 1987-05-05 US disclosed
EP-0159566-A1 Novel piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient KANEBO, LTD. (JP) 1985-10-30 EP disclosed
EP-0159566-A1 Novel piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient KANEBO, LTD. (JP) 1985-10-30 EP disclosed